Skip to main content
. 2023 Oct 16;24(20):15233. doi: 10.3390/ijms242015233

Figure 1.

Figure 1

Endometrial cancer cells with PD-L1 expression will be able to inhibit T-cell activity by binding the PD-L1 to PD-1 of T-cell.